BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 18, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
March 23, 2000
View Archived Issues
Enrollment completed in European phase III trial of platelet pathogen inactivation system
Read More
FDA approves modifications to Dermagraft IDE for diabetic foot ulcers
Read More
Agouron solves atomic structure of Chk1, a cell cycle-regulating protein
Read More
SBIR grant to Antigen Express for MHC class II-enhanced cancer vaccines
Read More
Gliatech's anticomplement MAb reduces inflammation in preclinical model
Read More
AxyS Pharmaceuticals ends 1999 with three key programs in preclinical testing
Read More
Baxter and AlphaOne to codevelop rAAT treatment of hereditary emphysema
Read More
Phase II trial of Oncophage begins for treatment of NHL
Read More
Columbia Laboratories reacquires U.S. rights to Advantage-S
Read More
Millennium and MorphoSys expand antibody development agreement
Read More
SkyePharma and Bioglan establish marketing agreement for Solarase
Read More
Esteve and DevCo collaborate on neuroscience program
Read More
Ilex Oncology initiates second phase I trial of ILX-23-7553
Read More
Ligand moves LGD-2226 towards human studies
Read More
IND filed with FDA for ISAtx-247
Read More
New cephalosporin antibiotics for beta-lactam-resistant infections
Read More
Microbially produced antitumor antibiotics discovered at Mercian
Read More
Abeta peptide formation inhibitors from Roche for the treatment of AD
Read More
Takeda's new benzothiepin derivatives enhance bone formation
Read More
International patent issued for SB's novel C3A receptor ligands and their use in inflammation
Read More
Antiplatelet agents designed at Toray with affinity for thromboxane and prostanoid receptors
Read More
Merck compound L-754030 and use in circadian rhythm disorders covered by new patent
Read More
Pivotal trial data presented at ACC meeting support use of Novastan in HIT
Read More
Genentech outlines clinical trial plan for TNKase in combination with leading antithrombotics
Read More
Ebelsen studied in models of lung injury, lung inflammation
Read More
E-5564 proves safe and effective in humans with experimentally induced endotoxemia
Read More
Pharmacokinetics, efficacy and safety of PNU-83757 examined in patients with ED
Read More
Leukocytosis following AMD-3100 is dose-related and reversible
Read More